Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of all forms of first aid kits, surgical dressing, surgical plastics and other medical disposables[1]
- Market Cap ₹ 26.3 Cr.
- Current Price ₹ 18.2
- High / Low ₹ 27.5 / 15.0
- Stock P/E 12.7
- Book Value ₹ 25.6
- Dividend Yield 0.00 %
- ROCE 8.39 %
- ROE 5.76 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.71 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.33% over past five years.
- Company has a low return on equity of 6.04% over last 3 years.
- Company has high debtors of 153 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 79.85 | 83.71 | |
52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.14 | 74.66 | 79.35 | |
Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.22 | 5.19 | 4.36 |
OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.34% | 6.50% | 5.21% |
0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.13 | 0.26 | |
Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.09 | 1.93 | 1.33 |
Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.60 | 0.50 |
Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.79 | 2.79 |
Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | 27.96% | 26.16% |
2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 2.01 | 2.07 | |
EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.39 | 1.43 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 9% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 0% |
3 Years: | 38% |
TTM: | 3% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -10% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 | 14.43 |
Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 20.48 | 22.53 |
11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.89 | 12.46 | |
7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 15.23 | 22.78 | |
Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 |
2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.53 | 2.95 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 | 0.00 |
30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 60.40 | 69.25 | |
Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
-0.99 | 3.15 | -2.44 | 5.77 | 3.84 | 3.80 | |||
1.58 | -0.71 | -1.16 | -1.16 | -0.22 | 0.51 | |||
-0.07 | -3.11 | 4.44 | -4.63 | -4.36 | -2.66 | |||
Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 | -0.75 | 1.65 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 | 115.51 | 152.52 |
Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 | 138.71 | 126.64 |
Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 | 75.97 | 104.03 |
Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 | 178.25 | 175.13 |
Working Capital Days | 129.43 | 211.19 | 222.82 | 194.70 | 221.28 | 179.13 | 187.69 | 181.65 |
ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 10.07% | 9.62% | 8.39% |
Documents
Announcements
-
Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (LODR) Regulation, 2015 For The Year Ended On 31St March, 2025
29 May - No fund raising or deviation under SEBI LODR for year ended March 31, 2025.
-
Financial Results For March 31, 2025
28 May - Audited FY25 financial results with unmodified audit opinion and related party transactions disclosed.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On May 28, 2025 For Financial Results For Half Year And Financial Year Ended March 31, 2025
28 May - Audited FY25 financial results with unmodified audit opinion; related party transactions disclosed.
-
Board Meeting Intimation for Intimation Of Board Meeting For The Audited Financial Results For The Half Year And Financial Year Ended March 31, 2025
23 May - Board meeting on May 28 to approve FY25 audited results; trading window closed till 48 hours post announcement.
-
Non Applicability Of SEBI Circular (SEBI/HO/DDHS/CIR/P/2018/144) Dated 26 November 2018 For The Year Ended March 31, 2025.
9 May - Company confirms non-applicability of SEBI Large Corporate criteria as per 2018 circular.
Business Overview:[1][2]
Company is a WHO cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter of sterile surgical wound dressing products and medical disposables. It deals in all kinds of surgical, pharmaceutical, medicine items including first aid kits, surgical dressings including sterile medicated wound dressings, sterile advanced hemostatic dressings, chitosan, oxidized cellulose and gelatin sponges, medical bandages, medical kits, Home Based New Born (HBNC) and other kits, face masks, and dealing in various items and Turnkey projects for all of the above products and other ancillary business